Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 527

1.

High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer.

Aceto GM, Solano AR, Neuman MI, Veschi S, Morgano A, Malatesta S, Chacon RD, Pupareli C, Lombardi M, Battista P, Marchetti A, Mariani-Costantini R, Podestà EJ.

Breast Cancer Res Treat. 2010 Aug;122(3):671-83. doi: 10.1007/s10549-009-0596-6. Epub 2009 Oct 23.

PMID:
19851859
[PubMed - indexed for MEDLINE]
2.

Can a phenotype for recessive inheritance in breast cancer be defined?

Ellberg C, Jönsson G, Olsson H.

Fam Cancer. 2010 Dec;9(4):525-30. doi: 10.1007/s10689-010-9355-4.

PMID:
20549370
[PubMed - indexed for MEDLINE]
3.

Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study.

de Sanjosé S, Léoné M, Bérez V, Izquierdo A, Font R, Brunet JM, Louat T, Vilardell L, Borras J, Viladiu P, Bosch FX, Lenoir GM, Sinilnikova OM.

Int J Cancer. 2003 Sep 10;106(4):588-93.

PMID:
12845657
[PubMed - indexed for MEDLINE]
4.

Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families.

Arcand SL, Maugard CM, Ghadirian P, Robidoux A, Perret C, Zhang P, Fafard E, Mes-Masson AM, Foulkes WD, Provencher D, Narod SA, Tonin PN.

Breast Cancer Res Treat. 2008 Apr;108(3):399-408. Epub 2007 May 31.

PMID:
17541742
[PubMed - indexed for MEDLINE]
5.

Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia.

Konecny M, Milly M, Zavodna K, Weismanova E, Gregorova J, Mlkva I, Ilencikova D, Kausitz J, Bartosova Z.

Breast Cancer Res Treat. 2011 Feb;126(1):119-30. doi: 10.1007/s10549-010-1325-x. Epub 2011 Jan 4.

PMID:
21203900
[PubMed - indexed for MEDLINE]
6.

Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.

Lee DS, Yoon SY, Looi LM, Kang P, Kang IN, Sivanandan K, Ariffin H, Thong MK, Chin KF, Mohd Taib NA, Yip CH, Teo SH.

Breast Cancer Res. 2012 Apr 16;14(2):R66.

PMID:
22507745
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma.

Monnerat C, Chompret A, Kannengiesser C, Avril MF, Janin N, Spatz A, Guinebretière JM, Marian C, Barrois M, Boitier F, Lenoir GM, Bressac-de Paillerets B.

Fam Cancer. 2007;6(4):453-61. Epub 2007 Jul 12.

PMID:
17624602
[PubMed - indexed for MEDLINE]
8.

Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online.

De Benedetti VM, Radice P, Pasini B, Stagi L, Pensotti V, Mondini P, Manoukian S, Conti A, Spatti G, Rilke F, Pierotti MA.

Hum Mutat. 1998;12(3):215.

PMID:
10660329
[PubMed - indexed for MEDLINE]
9.

PML protein expression in hereditary and sporadic breast cancer.

Plevová P, Bouchal J, Fiurásková M, Foretová L, Navrátilová M, Zapletalová J, Curík R, Kubala O, Prokop J, Kolár Z.

Neoplasma. 2007;54(4):263-8.

PMID:
17822314
[PubMed - indexed for MEDLINE]
10.

Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases.

Malone KE, Daling JR, Neal C, Suter NM, O'Brien C, Cushing-Haugen K, Jonasdottir TJ, Thompson JD, Ostrander EA.

Cancer. 2000 Mar 15;88(6):1393-402.

PMID:
10717622
[PubMed - indexed for MEDLINE]
11.
12.

Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer.

Chappuis PO, Hamel N, Paradis AJ, Deschênes J, Robidoux A, Potvin C, Cantin J, Tonin P, Ghadirian P, Foulkes WD.

Clin Genet. 2001 Jun;59(6):418-23.

PMID:
11453973
[PubMed - indexed for MEDLINE]
13.

BRCA-associated breast cancer: absence of a characteristic immunophenotype.

Robson M, Rajan P, Rosen PP, Gilewski T, Hirschaut Y, Pressman P, Haas B, Norton L, Offit K.

Cancer Res. 1998 May 1;58(9):1839-42.

PMID:
9581822
[PubMed - indexed for MEDLINE]
Free Article
14.

Analysis of BRCA1, TP53, and TSG101 germline mutations in German breast and/or ovarian cancer families.

Balz V, Prisack HB, Bier H, Bojar H.

Cancer Genet Cytogenet. 2002 Oct 15;138(2):120-7.

PMID:
12505256
[PubMed - indexed for MEDLINE]
15.

Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families.

Valarmathi MT, Sawhney M, Deo SS, Shukla NK, Das SN.

Hum Mutat. 2004 Feb;23(2):205.

PMID:
14722926
[PubMed - indexed for MEDLINE]
16.

Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.

Martin AM, Blackwood MA, Antin-Ozerkis D, Shih HA, Calzone K, Colligon TA, Seal S, Collins N, Stratton MR, Weber BL, Nathanson KL.

J Clin Oncol. 2001 Apr 15;19(8):2247-53.

PMID:
11304778
[PubMed - indexed for MEDLINE]
Free Article
17.

Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients.

Manguoglu AE, Lüleci G, Ozçelik T, Colak T, Schayek H, Akaydin M, Friedman E.

Hum Mutat. 2003 Apr;21(4):444-5.

PMID:
12655560
[PubMed - indexed for MEDLINE]
18.

Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.

Adem C, Reynolds C, Soderberg CL, Slezak JM, McDonnell SK, Sebo TJ, Schaid DJ, Myers JL, Sellers TA, Hartmann LC, Jenkins RB.

Cancer. 2003 Jan 1;97(1):1-11.

PMID:
12491499
[PubMed - indexed for MEDLINE]
Free Article
19.

BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients.

Keshavarzi F, Javadi GR, Zeinali S.

Fam Cancer. 2012 Mar;11(1):57-67. doi: 10.1007/s10689-011-9477-3.

PMID:
21918854
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk